Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Halil İbrahim Yakar"'
Autor:
Halil İbrahim Yakar, Handan Inonu Koseoglu, Ahmet Cemal Pazarlı, Gökhan Aykun, Mustafa Parti, Hacer Kılınç
Publikováno v:
Respiratory Case Reports. 11:123-126
Autor:
Serkan, Gungor, Ulug Mutlu, Gunaydin, Halil Ibrahim, Yakar, Eda Tanrikulu, Simsek, Ayten Guner, Akbiyik, Havva, Keskin
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 33(1)
To evaluate the diagnostic performance of total lesion glycolysis (TLG) obtained by 18F-FDG PET/ CT to differentiate malignant solitary pulmonary nodules (SPNs) from benign ones.Observational study.Department of Nuclear Medicine, Istanbul Medeniyet U
Publikováno v:
Tuberk Toraks. 69:74-83
The COVID-19 outbreak that spread in December 2019 has caused the death of millions of people in a short time. Many studies published recently have shown that many cytokines (interleukin (IL) IL-1, IL-2, IL-6, TNF and IFN-) are significantly increase
Autor:
Asiye Kanbay, Halil İbrahim Yakar
Publikováno v:
Turkiye Klinikleri Archives of Lung. 20:6-12
Autor:
Halil İbrahim Yakar, Asiye Kanbay
Publikováno v:
Respiratory Case Reports. 9:66-69
Autor:
Serkan Gungor, Halil İbrahim Yakar
Publikováno v:
Interact Cardiovasc Thorac Surg
A 61-year-old male patient with known kidney dysfunction who underwent a non-contrast thorax CT and was then referred to our department for metabolic assessment of solitary pulmonary nodule (SPN). The patient underwent dynamic FDG PET/CT to different
Autor:
Ahmet Cemal Pazarlı, Ruken Yuksekkaya Celıkyay, Timur Ekiz, Halil İbrahim Yakar, Handan İnönü Köseoğlu
Publikováno v:
Tuberkuloz ve toraks. 69(2)
Introduction The objective of this study was to investigate the clinical and radiological features and pulmonary function tests (PFTs) in patients with the pulmonary involvement of systemic rheumatic diseases (SRDs). Materials and methods This study
Autor:
Asiye Kanbay, Halil İbrahim Yakar
Publikováno v:
Nigerian journal of clinical practice. 23(8)
Background: Inhaler corticosteroids (ICS) are the most commonly used antiinflammatory drugs in the treatment of asthma. Although systemic adverse effects are minimal, patients hesitate to use ICS for a long time because of corticophobia. There is no
Autor:
Halil İbrahim Yakar, Asiye Kanbay
WOS:000590890600007 PubMed: 33295724 Introduction: COPD is an inflammatory disease characterized by persistent respiratory symptoms and airflow limitation. Currently, it has been demonstrated in some studies that eosinophil and T helper-2 mediated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7efd72424e7832d90eec511bc5d4bc56
https://hdl.handle.net/20.500.12881/3046
https://hdl.handle.net/20.500.12881/3046
Publikováno v:
Respiratory Case Reports. 7:158-161